Nanalysis Scientific Corp. NSCIF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.29% | -9.91% | -13.53% | -5.67% | 5.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.29% | -9.91% | -13.53% | -5.67% | 5.90% |
| Cost of Revenue | -0.03% | -3.28% | -9.76% | -9.46% | -2.31% |
| Gross Profit | -18.56% | -25.98% | -23.25% | 6.39% | 34.39% |
| SG&A Expenses | -25.71% | -15.96% | -12.28% | -7.93% | -5.32% |
| Depreciation & Amortization | -24.35% | -22.64% | -28.19% | -14.32% | -7.73% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.18% | -7.65% | -12.13% | -9.31% | -3.49% |
| Operating Income | 42.74% | -28.44% | -6.12% | 36.51% | 53.16% |
| Income Before Tax | 66.42% | 54.12% | 59.04% | -64.88% | -0.39% |
| Income Tax Expenses | 347.92% | -74.68% | 179.49% | -99.37% | -100.76% |
| Earnings from Continuing Operations | 66.27% | 54.15% | 58.85% | -45.33% | 6.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.27% | 54.15% | 58.85% | -45.33% | 6.30% |
| EBIT | 42.74% | -28.44% | -6.12% | 36.51% | 53.16% |
| EBITDA | -276.18% | -402.57% | -673.68% | 33.09% | 95.05% |
| EPS Basic | 69.36% | 56.42% | 60.02% | -36.78% | 14.36% |
| Normalized Basic EPS | 45.53% | 11.82% | 27.70% | 32.65% | 45.48% |
| EPS Diluted | 67.38% | 54.38% | 58.52% | -25.96% | 10.60% |
| Normalized Diluted EPS | 45.53% | 11.82% | 27.70% | 32.65% | 45.48% |
| Average Basic Shares Outstanding | 12.02% | 6.63% | 3.68% | 5.53% | 8.06% |
| Average Diluted Shares Outstanding | 12.02% | 6.63% | 3.68% | 5.53% | 8.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |